- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Medicamen Organics has announced a board meeting to approve the financial results for the quarter and half-year. The board approved the audited standalone and consolidated results for the half year and financial year ended March 31, 2025, with a clean auditor’s opinion. The company confirmed the full utilization of funds raised through its IPO and preferential issue of 4,65,910 fully convertible warrants allotted in March 2025. No dividends or additional strategic updates were shared.